Related Experiment Video
Updated: Jun 8, 2026
02:21
Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
Published on: March 15, 2024
Predicting delay in presentation in men with Peyronie's disease
John P Mulhall1, Byron Alex2, Judy M Choi2
1Memorial Sloan-Kettering Cancer Center, Urology, New York, NY, USA.
The Journal of Sexual Medicine
|October 9, 2010
Summary
Many men with Peyronie's disease (PD) delay seeking urological care. Delayed presentation is linked to older age, long-term relationships, dorsal curvature, and simpler deformities.
Area of Science:
- Urology
- Andrology
- Men's Health
Background:
- Peyronie's disease (PD) significantly impacts men's quality of life.
- Delayed presentation to urologists is common, but reasons remain unclear.
Purpose of the Study:
- To identify characteristics differentiating early versus delayed presentation for PD.
- To determine predictors associated with delayed medical evaluation for PD.
Main Methods:
- Retrospective analysis of 482 patients with initial PD evaluation.
- Standardized history, physical examination, and deformity assessment.
- Statistical and multivariable analyses to identify presentation predictors.
Main Results:
- 39% of patients presented more than 12 months after symptom onset.
- Delayed presenters were older (OR=4.0), in long-term relationships (OR=3.6), and had dorsal curvature (OR=2.5).
- Less severe curvature (<45°, OR=3.3) and simpler deformities (OR=1.5) also predicted delay.
Conclusions:
- Approximately one-third of men experience delayed presentation for PD.
- Factors influencing delayed presentation include patient age, relationship status, and curvature characteristics.
Related Concept Videos
01:20Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
01:17Male Sexual Response: Erection & Ejaculation
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...